Clinical Trials Browser

Phase 1 × Completed × Epstein-Barr Virus Infections × Clear all

NCT01535885 2021-10-25

ACE

Phase 1 Completed

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT00058591 2020-01-18

SCAEBV

Phase 1 Completed

Epstein-Barr Virus Infections

NCT01800071 2018-07-17

A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma

Phase 1 Completed

Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT00706316 2015-07-10

NPC-CTL

Phase 1 Completed

Nasopharyngeal Neoplasms, Neoplasm Metastasis, Recurrence, Epstein-Barr Virus Infections

NCT00058812 2015-01-29

ETNA

Phase 1 Completed

Epstein-Barr Virus Infections

NCT01070797 2014-09-04

VIRAGE

Phase 1 Completed

Adenoviridae Infections, Cytomegalovirus Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT00078546 2012-07-30

CLANC

Phase 1 Completed

Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT00779337 2012-05-22

EPL

Phase 1 Completed

Lymphoma, Epstein-Barr Virus Infections

NCT01147991 2012-02-28

Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer

Phase 1 Completed

GastrointestinalHead & NeckLymphoid

Burkitt Lymphoma, Head and Neck Neoplasms, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoproliferative Disorders, Nasopharyngeal Neoplasms, Stomach Neoplasms, Lymphoma, Large-Cell, Immunoblastic, Epstein-Barr Virus Infections, Lymphoma, Extranodal NK-T-Cell